Recent Articles

Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer

| February 17, 2017 | 0 Comments

Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer Results from a recent clinical trial showed that extending adjuvant therapy with an aromatase inhibitor to 10 years after initial treatment can have important benefits for postmenopausal women with early-stage hormone receptor–positive breast cancer.See Original Article

Continue Reading

Cancer Moonshot Moves Forward, Bringing Funding Opportunities for Researchers

| February 17, 2017 | 0 Comments

Cancer Moonshot Moves Forward, Bringing Funding Opportunities for Researchers NCI has issued a series of funding opportunity announcements aligned with goals of the recommendations in the Beau Biden Cancer Moonshot℠ Blue Ribbon Panel report released last fall. See Original Article

Continue Reading

NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued Progress

| February 15, 2017 | 0 Comments

NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued Progress Dr. Julia Rowland, director of NCI’s Office of Cancer Survivorship, on the office’s 20th anniversary and efforts to ensure continued progress in survivorship research and improve survivors’ lives.See Original Article Crizotinib Approval Expanded for Advanced Lung Cancer The FDA has approved uses of […]

Continue Reading

Potential New Cancer Therapy Could Target Tumors Two Ways

| February 15, 2017 | 0 Comments

Potential New Cancer Therapy Could Target Tumors Two Ways A team of researchers has developed a potential new therapy that may work in two distinct ways to attack tumors, by directly killing cancer cells and immune cells that can suppress the anti-cancer immune response.See Original Article

Continue Reading

Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy

| February 13, 2017 | 0 Comments

Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy Encouraging findings from several early-stage clinical trials featured at the 2016 American Society of Clinical Oncology annual meeting support the promise of precision medicine and immunotherapy.See Original Article Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer In a small clinical trial, more than […]

Continue Reading

Combination Therapy Improves Survival for Some Men with Recurrent Prostate Cancer

| February 13, 2017 | 0 Comments

Combination Therapy Improves Survival for Some Men with Recurrent Prostate Cancer Long-term results from an NCI-sponsored clinical trial suggest that adding androgen deprivation therapy to radiation therapy improves the survival of some men with recurrent prostate cancer.See Original Article

Continue Reading

CA-125 Testing, CT Scans Still Used for Ovarian Cancer Surveillance Despite Lack of Proven Benefit

| February 12, 2017 | 0 Comments

CA-125 Testing, CT Scans Still Used for Ovarian Cancer Surveillance Despite Lack of Proven Benefit A new study shows clinicians continue to use CA-125 testing and CT scans to monitor for recurrences although the benefit of these tests has not been proven.See Original Article CDC Updates Recommendations on HPV Vaccine Updated CDC recommendations advise those […]

Continue Reading

The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.

| February 11, 2017 | 0 Comments

The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D. Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future. See Original Article New on NCI’s Websites for June 2016 An NCI Cancer Currents blog post that provides updates on new NCI websites […]

Continue Reading

FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer

| February 10, 2017 | 0 Comments

FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer The FDA has approved the drug pembrolizumab to treat patients with advanced non-small cell lung cancer (NSCLC) whose tumors express a protein called PD-L1.See Original Article Mouse Study Points to Mechanism Linking Obesity and Colorectal Cancer Risk A missing hormone in obese mice may help […]

Continue Reading

Grantee Spotlight: Marta Torroella-Kouri, Ph.D. – Studying the Role of Obesity and Breast Fat Tissue Inflammation in African American Women with Breast Cancer

| February 10, 2017 | 0 Comments

Grantee Spotlight: Marta Torroella-Kouri, Ph.D. – Studying the Role of Obesity and Breast Fat Tissue Inflammation in African American Women with Breast Cancer Dr. Marta Torroella-Kouri, a CRCHD-NCI R21 grantee, is studying the role of obesity and breast fat tissue inflammation in breast cancer. See Original Article FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer The […]

Continue Reading